Tue. 7 May 2024, 6:04am ET
Benzinga
Earnings, Earnings Misses, News
X4 Pharmaceuticals (NASDAQ:XFOR) reported quarterly losses of $(0.26) per share which missed the analyst consensus estimate of $(0.16) by 62.5 percent. This is a 62.5 percent decrease over losses of $(0.16) per share from the same period last year.